Abacavir contraindications

Abacavir
ZIAGEN® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Clinical Studies
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

Contraindications

• ZIAGEN is contraindicated in patients with:previously demonstrated hypersensitivity to abacavir or any other component of the products.

• NEVER restart ZIAGEN or any other abacavir-containing product following a hypersensitivity reaction to abacavir, regardless of HLA-B*5701 status.

• Moderate or severe hepatic impairment [see Dosage and Administration].

References

Adapted from the FDA Package Insert.